Authors: SCHIEDEL D AARTS M GRUCHALLA R RIEDER MJ

Citation: D. Schiedel et al., SULFONAMIDE-SPECIFIC HAPTENS DURING SULFONAMIDE THERAPY, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 8-8

Authors: AARTS M GRUCHALLA R RIEDER MJ

Citation: M. Aarts et al., SULFONAMIDE-SPECIFIC HAPTENS DURING SULFONAMIDE THERAPY, British journal of clinical pharmacology, 42(5), 1996, pp. 679-679

Authors: AARTS M RIEDER MJ

Citation: M. Aarts et Mj. Rieder, SULFONAMIDE-SPECIFIC HAPTENS DURING THERAPY AND ADVERSE DRUG-REACTIONS, Pediatric research, 39(4), 1996, pp. 410-410

Authors: VANLOCHEM EG BAKKER A SNIJDER S AARTS M DEGAST GC GOULMY E

Citation: Eg. Vanlochem et al., EPSTEIN-BARR-VIRUS INFECTION ABROGATES THE STIMULATORY CAPACITY OF B-CELLS TO A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-RESTRICTED PROLIFERATIVE T-CELL CLONE, Human immunology, 42(2), 1995, pp. 137-144

Authors: AARTS M RIEDER MJ BIRD IA FREEMAN D

Citation: M. Aarts et al., IN-VIVO SUPPRESSION OF T-LYMPHOCYTE PROLIFERATION-ASSOCIATED WITH METABOLISM OF SULFAMETHOXAZOLE TO ITS HYDROXYLAMINE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 135-135